Mylan has launched its generic version of GlaxoSmithKline’s respiratory blockbuster, Advair, at a 70% discount ... while the patent on GSK’s Diskus inhaler expired in 2016.

“We expect the recently approved generic Advair to have minimal impact on this highly differentiated product, the first approved once daily single inhaler triple therapy for COPD,” said GSK ...

In January 2024, 22-year-old Cole Schmidtknecht went to Walgreens to fill a prescription for an asthma inhaler ... were no ...

This upside was driven by solid sales growth of the asthma inhaler Trelegy Ellipta ... was offset by the use of authorized generic versions of Advair and Flovent. In General Medicines, Respiratory ...

There are many types of asthma inhalers. They differ in whether they're used for quick relief or long-term control, what type of drug they contain, and how the medications are delivered to the lungs.

PBMs would be required to pay pharmacies within 30 days, cutting down on long delays for drug reimbursement ... forced to forego the purchase of his inhaler because of an unexpected price increase.

Introduction: The incidence of asthma exacerbations in patients receiving salmeterol/fluticasone propionate (Seretide™ or Advair ®) is ... daily from a Diskus™ inhaler for a 4-week run ...

Danish drugmaker Novo Nordisk is prepared to enter the Indian market and other markets with its blockbuster drug Ozempic, despite losing patent exclusivity early next year. “Even as we face ...

A rescue inhaler is a type of inhaler that dispenses medication to relieve or stop the symptoms of an asthma attack. A rescue inhaler is a type of inhaled medication to help relieve the symptoms ...

Vital everyday medicines such as asthma inhalers and insulin could become ... Health Minister Mark Butler said drug makers in the US previously tried to pressure the Howard government to roll ...

HIV sales rose 14% driven by strong demand and increased market share for oral two-drug regimens, Dovato and Juluca, and long-acting regimens like Cabenuva and Apretude. GSK generates the majority ...